Use of inhibitors of prostaglandin synthesis in patients with breast cancer.
D000082:Acetaminophen / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000517:prevention & control / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009362:Neoplasm Metastasis; D010919:Placebos; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis*
D010919:Placebos; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000082:Acetaminophen; D001241:Aspirin